GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » InVivo Therapeutics Holdings Corp (FRA:04I) » Definitions » Cyclically Adjusted Book per Share

InVivo Therapeutics Holdings (FRA:04I) Cyclically Adjusted Book per Share : €6,695.99 (As of Sep. 2023)


View and export this data going back to 2015. Start your Free Trial

What is InVivo Therapeutics Holdings Cyclically Adjusted Book per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

InVivo Therapeutics Holdings's adjusted book value per share for the three months ended in Sep. 2023 was €2.691. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is €6,695.99 for the trailing ten years ended in Sep. 2023.

During the past 12 months, InVivo Therapeutics Holdings's average Cyclically Adjusted Book Growth Rate was -4.80% per year. During the past 3 years, the average Cyclically Adjusted Book Growth Rate was 18.40% per year. During the past 5 years, the average Cyclically Adjusted Book Growth Rate was 13.30% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted Book Growth Rate using Cyclically Adjusted Book per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted Book Growth Rate of InVivo Therapeutics Holdings was 62.10% per year. The lowest was 4.50% per year. And the median was 15.50% per year.

As of today (2024-06-14), InVivo Therapeutics Holdings's current stock price is €0.2545. InVivo Therapeutics Holdings's Cyclically Adjusted Book per Share for the quarter that ended in Sep. 2023 was €6,695.99. InVivo Therapeutics Holdings's Cyclically Adjusted PB Ratio of today is 0.00.


InVivo Therapeutics Holdings Cyclically Adjusted Book per Share Historical Data

The historical data trend for InVivo Therapeutics Holdings's Cyclically Adjusted Book per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

InVivo Therapeutics Holdings Cyclically Adjusted Book per Share Chart

InVivo Therapeutics Holdings Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Cyclically Adjusted Book per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3,641.38 3,347.92 3,314.78 5,817.20 7,012.63

InVivo Therapeutics Holdings Quarterly Data
Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23
Cyclically Adjusted Book per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7,526.89 7,012.63 7,223.89 6,684.70 6,695.99

Competitive Comparison of InVivo Therapeutics Holdings's Cyclically Adjusted Book per Share

For the Biotechnology subindustry, InVivo Therapeutics Holdings's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


InVivo Therapeutics Holdings's Cyclically Adjusted PB Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, InVivo Therapeutics Holdings's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where InVivo Therapeutics Holdings's Cyclically Adjusted PB Ratio falls into.



InVivo Therapeutics Holdings Cyclically Adjusted Book per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Book per Share and the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years.

What is Cyclically Adjusted Book per Share? How do we calculate Cyclically Adjusted Book per Share?

Cyclically Adjusted Book per Share is the average of the inflation adjusted Book Value per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted Book per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the book value per share from 2001 through 2010.

We adjusted the 2001 book value per share data with the total inflation from 2001 through 2010 to the equivalent book value in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's book value is $1 a share in 2001, then the 2001's equivalent book value in 2010 is $1.4 a share. If Wal-Mart's book value is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 book value in 2010 is $1.35. So on and so forth, you get the equivalent book value per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, InVivo Therapeutics Holdings's adjusted Book Value per Share data for the three months ended in Sep. 2023 was:

Adj_Book= Book Value per Share /CPI of Sep. 2023 (Change)*Current CPI (Sep. 2023)
=2.691/129.8595*129.8595
=2.691

Current CPI (Sep. 2023) = 129.8595.

InVivo Therapeutics Holdings Quarterly Data

Book Value per Share CPI Adj_Book
201312 8,961.905 98.326 11,836.032
201403 6,240.000 99.695 8,128.064
201406 8,318.548 100.560 10,742.322
201409 8,412.000 100.428 10,877.248
201412 3,839.200 99.070 5,032.382
201503 6,820.144 99.621 8,890.290
201506 9,541.958 100.684 12,306.972
201509 10,559.722 100.392 13,659.326
201512 10,572.109 99.792 13,757.448
201603 21,920.588 100.470 28,332.689
201606 19,690.588 101.688 25,145.616
201609 17,111.111 101.861 21,814.437
201612 16,049.123 101.863 20,460.199
201703 13,105.848 102.862 16,545.620
201706 9,815.116 103.349 12,332.822
201709 6,569.780 104.136 8,192.668
201712 4,668.306 104.011 5,828.454
201803 3,245.192 105.290 4,002.479
201806 -300.368 106.317 -366.881
201809 1,396.737 106.507 1,702.987
201812 1,141.176 105.998 1,398.071
201903 965.834 107.251 1,169.437
201906 745.894 108.070 896.288
201909 562.175 108.329 673.905
201912 228.098 108.420 273.203
202003 84.114 108.902 100.302
202006 45.607 108.767 54.451
202009 33.938 109.815 40.133
202012 16.684 109.897 19.715
202103 15.643 111.754 18.177
202106 14.116 114.631 15.991
202109 12.989 115.734 14.574
202112 11.697 117.630 12.913
202203 10.279 121.301 11.004
202206 8.714 125.017 9.052
202209 7.330 125.227 7.601
202212 6.118 125.222 6.345
202303 4.053 127.348 4.133
202306 3.441 128.729 3.471
202309 2.691 129.860 2.691

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.


InVivo Therapeutics Holdings  (FRA:04I) Cyclically Adjusted Book per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted Book per Share may underestimate the company's equity. Cyclically Adjusted PB Ratio can seem to be too high even the actual PB Ratio is low.

For the Cyclically Adjusted PB Ratio, the book value of the past 10 years are inflation-adjusted and averaged. The result is used for P/B calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted PB Ratio is also called CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

InVivo Therapeutics Holdings's Cyclically Adjusted PB Ratio of today is calculated as

Cyclically Adjusted PB Ratio=Share Price/Cyclically Adjusted Book per Share
=0.2545/6695.99
=0.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Cyclically Adjusted PB Ratio works better for cyclical companies. It gives you a better idea on the company's real book value.


InVivo Therapeutics Holdings Cyclically Adjusted Book per Share Related Terms

Thank you for viewing the detailed overview of InVivo Therapeutics Holdings's Cyclically Adjusted Book per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


InVivo Therapeutics Holdings (FRA:04I) Business Description

Traded in Other Exchanges
Address
One Kendall Square, Suite B14402, Building 1400 West, 4th Floor, Cambridge, MA, USA, 02139
InVivo Therapeutics Holdings Corp is a research and clinical stage biomaterials and biotechnology company. It focuses on the treatment of spinal cord injury. The company's product pipeline consists of Neuro spinal scaffold and Bioengineered neural trails. The firm has a clinical development program for acute spinal cord injury and a preclinical development program for chronic spinal cord injury.

InVivo Therapeutics Holdings (FRA:04I) Headlines

No Headlines